NCT01745172 Carotid Body Removal for the Treatment of Resistant Hypertension Status COMPLETED Phase NA
NCT01743911 Tadalafil Effects in Left Ventricle Diastolic Dysfunction in Resistant Hypertensive Patients Status COMPLETED Phase NA
NCT01743183 Influence of Respiratory Muscle Training in Elderly Hypertensive Women With Respiratory Muscle Weakness Status COMPLETED Phase NA
NCT01742923 Tailored Intervention to Improve Medication Adherence in Patients With Hypertension Status COMPLETED Phase NA
NCT01741922 Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients Status COMPLETED Phase PHASE3
NCT01741779 Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function Status COMPLETED Phase NA
NCT01741766 The Effects of Stretching Training on Arterial Function and Autonomic Control Status COMPLETED Phase NA
NCT01736488 Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive Patients Status COMPLETED Phase PHASE4
NCT01734096 Renal Response to Lower Body Negative Pressure in Pre-hypertensive States Status COMPLETED Phase PHASE4
NCT01729988 Carotid Body Removal for the Treatment of Resistant Hypertension: a Pilot Study Status COMPLETED Phase NA
NCT01719185 The Effect of Phentermine and B12 on Weight Loss Among Obese Patients Status COMPLETED Phase EARLY_PHASE1
NCT01715584 Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics Status UNKNOWN Phase PHASE4
NCT01713920 Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM Status COMPLETED Phase PHASE4
NCT01713270 Renal Sympathetic Denervation in Patients With Drug-resistant Hypertension and Symptomatic Atrial Fibrillation Status UNKNOWN Phase NA
NCT01712139 Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions Status COMPLETED Phase NA
NCT01712126 Crossover Bioequivalence Study of Irbesartan Hydrochlorothiazide 300/25 mg Tablets Under Fed Conditions Status COMPLETED Phase NA